Biology & biomedicine Technological offers
Modulating compounds of KChIP2 and its use for the treatment of cardiovascular pathologies
- Details
- Category: Technological offers
-
18 Jun 2019
CSIC and UAM have developed compounds that positively modulate protein-protein interactions that involve KChIP2protein. Industrial partners from the pharmaceutical industry are being sought to collaborate through a patent licence agreement.
Preclinical trial with efavirenz for the treatment of Niemann-Pick C disease
- Details
- Category: Technological offers
-
05 Apr 2019
A team of scientists from the Centro de Biología Molecular Severo Ochoa (CMBSO-CSIC) has developed a new treatment for the Niemann-Pick disease type C (NPC) based on the drug efavirenz. The study is at the preclinical stage.
Graphene implant for recording infraslow electrophysiological activity
- Details
- Category: Technological offers
-
25 Feb 2019
Scientists from the IMB-CNM of the CSIC, the CIBER-BNN, ICREA, the ICN2, the ICFO and IDIBAPS have developed and patented a flexible implant based on graphene for measuring electrophysiological activity. It has an outstanding sensibility for recording the most subtle activity of organs like brain, heart, nerves or spinal cord. This breaking technology has been successfully tested on brain and has been highlighted on the cover of Nature Materials. Now it is offered to the research and medical sector, especially neurology.
A smart patch enables easy diagnosis of cystic fibrosis
- Details
- Category: Technological offers
-
27 Feb 2019
A team led by CSIC scientists at the Institut de Microelectrònica de Barcelona (IMB-CNM), has developed a smart device based on a paper battery, which will make easier diagnosis of cystic fibrosis possible. This small device looks like a plaster and includes the sensing device and the energy source. Now, the scientific team is working for the clinical validation and transferring the device to the market.
Biocompatible hydrogel for the regeneration of cartilage and bone tissue
- Details
- Category: Technological offers
-
21 Dec 2018
A CSIC team has developed a biocompatible hydrogel for the regeneration of cartilage and bone tissue, which stands out for its lack of toxicity and high porosity. The mechanism is based on a method of cross-linking through diisocyanates.
